Community Strategic Initiatives seek to enable people and communities to improve the quality of life of people living with and those most at risk of HIV.

To achieve this, Positive Action strategy funding is provided in the form of:

Momentum grants (up to GBP 100,000 per year, over three years)

  • Advancing existing, evidence-based projects to enable sustainable scale-up with other funding/implementing partners
  • Larger financial commitments with expected co-investment with other funding bodies
  • Multiyear (3 years), staged-funding programmes

Innovator grants (up to GBP 50,000 per year, over two years)

  • First-time investments in novel ideas or in new contexts
  • 2 year pilot/seed community-led projects
Medium shot of kids holding hands

Momentum Grants
The Positive Action 2022 Round 3 funding for Momentum Inequalities is now closed. Applications have been reviewed and all applicants notified of outcome.

Innovator Grants

Positive Action invites applications to the 2023 Round 2 funding for Innovator Grants, focusing on proposals designed to implement community-based and community-led approaches for effective harm reduction and HIV prevention, testing, and treatment programming for communities who engage in chemsex in Cambodia, Indonesia, Malaysia, the Philippines, Thailand and Vietnam. This includes gay, bisexual men and other men who have sex with men, transgender people, people who inject drugs and those engaged in sex work.1’

According to UNAIDS, people who inject drugs have 35 times greater risk than adults who do not inject drugs of acquiring HIV, transgender women have 14 times greater risk of acquiring HIV than adult women (15-49) in the general population, and gay men and other men who have sex with men have 28 times greater risk of acquiring HIV than adult men (15-49) in the general population.1

Chemsex, an increasing practice in some parts of the world, involves the use of specific drugs before or during planned sexual events to facilitate, enhance, prolong and sustain sex. The risk of transmission for HIV and other sexually transmitted infections (STIs) is increased as a result of chemsex drugs lowering inhibitions, which can lead to unsafe sexual and other behaviours. For example chemsex participants may be more likely to engage in intercourse without the use of condoms, engage in sex with multiple partners, not take antiretrovirals (ARVs) including pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) and in the case of injecting drugs, engage in unsafe practices such as sharing injecting equipment

Focus of call: Positive Action invites proposals designed to implement community-based and community-led approaches for effective harm reduction and HIV prevention, testing, and treatment programming for communities who engage in chemsex responding to at least two of the three themes:

  1. Community based awareness and education campaigns, including through the use of digital technologies
  2. Drive uptake of harm reduction and HIV prevention, care and treatment services
  3. Drive uptake of mental health services.

Applications that are selected for funding, will be enrolled in a joint research study led by ViiV Healthcare Positive Action, to demonstrate the impact from the programming implemented on chemsex and document learning. This is in recognition that the sector would benefit from more evidence of good practice on chemsex programming to enable practitioners to use this for the South-East context and beyond. Positive Action invites applications from 6 June 2023 (00:01 BST) to 29th June 2023 (23:59 BST). Applications will be reviewed by the ViiV Positive Action Technical Review Committee at their meeting in July 2023

Positive Action will award up to £50,000 per year over two years (i.e. up to £100,000 over a two-year period). The call is open to both Community Based Organisations and Non-Governmental Organisations working at the community level.

Positive Action will be hosting two Webinars to respond to questions that applications may have. Join the first Webinar at 9:00am BST on Friday 9th of June or the second Webinar at 9am BST on Friday 16th June.

Click here to download a more detailed guidance note in English.

Application Process

All applications must be submitted through the Cyber Grants Portal. You will need to register your profile to gain access even if you have been a previous Positive Action Grantee.

Completing your applications
Use the link provided to create your profile and to complete your application:

Please do not email applications to ViiV Healthcare or Positive Action staff members of Positive Action mailboxes. We will only accept applications via the online application system..

If you have any problems accessing the online system please review the FAQs and/or contact the Positive Action mailbox:

The application window is open until 29th June 2023 (23:59 BST). Applications will be reviewed by a Technical Review committee. Final decision and contracting will happen from July 2023 onwards. These dates are provided as a guide.


Amplify Impact enables the accompaniment, collaboration and learning needed to achieve the goals of the ViiV Healthcare Positive Action strategy, “Healthy Communities in a world free of AIDS”. 

The Paediatric Breakthrough partners, working with government and community, aim to locate, link, treat and retain mothers and children at risk or living with HIV.

Positive Action Challenges seek to find innovative solutions to a specific issue related to the HIV and AIDS epidemic.

Our COVID-19 Community Emergency Response Fund supported community-based organisations in their work to address the specific challenges that have arisen for people living with HIV or affected by HIV as a result of the COVID-19 pandemic.


  1. UNAIDS Global AIDS Update 2022 Full report — In Danger: UNAIDS Global AIDS Update 2022 


Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at or search for MHRA Yellowcard in the Google Play or Apple App store. By reporting side effects, you can help provide more information on the safety of this medicine.

If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.